New drug TML-6 passes first safety check in healthy people
NCT ID NCT06562114
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 25 times
Summary
This study tested the safety and how the body handles a new drug called TML-6 in 72 healthy adults. Participants received single or multiple doses to check for side effects and measure drug levels in the blood. The goal was to gather early safety information, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.